10.1016/j.neulet.2005.10.056 186 KondoriN
GLP-1 receptor agonists work by mimicking the action of endogenous GLP-1, a hormone that stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways
faqs GLP-1 microdosing is the use of very low, personalized doses of GLP-1 receptor agonists to support appetite control, blood sugar balance, and fat loss while minimizing side effects commonly seen with standard dosing
**In a consumer study of 109 women after 28 days
By improving gut health, increasing microbial diversity, and boosting SCFA production, we can help the body make and respond to GLP-1 in a more natural way